BiotechTube
Home/Alzamend Neuro/Mark Gustafson
MG

Mark Gustafson

Board Director, Audit Committee Chair

Alzamend Neuro

Therapeutic Areas

Alzheimer's DiseaseBipolar DisorderMajor Depressive DisorderPost-Traumatic Stress Disorder

Alzamend Neuro Pipeline

DrugIndicationPhase
AL001Bipolar DisorderPhase II
ALZN002Alzheimer's DiseasePreclinical

Leadership Team at Alzamend Neuro

SJ
Stephan Jackman
Founder/CEO
AH
Andrew H. Woo
Board Director
LF
Lynne Fahey McGrath
Board Director
JO
Jeffrey Oram
Board Director
TM
Thomas M. Wisniewski
Scientific Advisor
EM
Eric M. McDade
Scientific Advisor
TH
Terri Hunter
Technology Transfer Advisor
View full Alzamend Neuro profile